Facet Wealth, Inc. Geron Corp Transaction History

Facet Wealth, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$1.19 - $1.65 $15,386 - $21,334	-12,930 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$1.2 - $1.5 $390 - $487	-325 Reduced 2.45%	12,930 $18,000
Q4 2020 Apr 20, 2021	BUY	$1.55 - $2.05 $20,545 - $27,172	13,255 New	13,255 $21,000

250

374M

1.48M

1.18M

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.71B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Facet Wealth, Inc., based on Form 13F filings with the SEC.

Stay updated on Facet Wealth, Inc. with notifications on news.